Previous close | 28.43 |
Open | 28.21 |
Bid | 28.31 x 300 |
Ask | 28.41 x 100 |
Day's range | 27.99 - 29.22 |
52-week range | 15.11 - 45.58 |
Volume | |
Avg. volume | 1,160,667 |
Market cap | 4.115B |
Beta (5Y monthly) | 0.70 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.81 |
Earnings date | 13 May 2024 - 27 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 50.86 |
Immunovant (IMVT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
In this article, we will be taking a look at 11 oversold biotech stocks to buy right now. To skip our detailed analysis of the biotech sector, you can go directly to see the 5 Oversold Biotech Stocks To Buy Right Now. Dealmaking in Biotech Healthcare has been performing well so far in 2024, and […]
In this article, we will take a detailed look at the 10 Stocks George Soros and Insiders Are Crazy About. For a quick overview of such stocks, read our article 5 Stocks George Soros and Insiders Are Crazy About. The strange calm in the US stock markets following the latest hotter-than-expected CPI report has analysts scratching their heads. Many […]